Search results
Tematy dnia
7 gru 2017 · The overall absolute increase in breast cancers diagnosed among current and recent users of any hormonal contraceptive was 13 (95% CI, 10 to 16) per 100,000 person-years, or approximately 1...
- Review Article Necrotizing Soft-Tissue Infections D.L. Stevens and A.E. Bryant
Necrotizing infections can occur after major traumatic...
- Images in Clinical Medicine Pneumatosis Cystoides Intestinalis Y. Sugihara and H. Okada
A 48-year-old woman with a prolonged history of...
- Editorial Closing In on Treatment for Hemophilia B M. Porteus
Hemophilia is an X-linked recessive genetic bleeding...
- Perspective Clinical Firsts — Christiaan Barnard's Heart Transplantations S. McKellar
On December 3, 1967, South African cardiac surgeon...
- Original Article Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis S. Vedantham and Others
The post-thrombotic syndrome frequently develops in patients...
- Editorial Oral Contraceptives and The Small Increased Risk of Breast Cancer D.J. Hunter
In this issue of the Journal, Mørch et al. 1 present the...
- Clinical Problem-Solving An Unusual Cause of Leg Pain N.P. Kelly and Others
A 67-year-old woman presented to her primary care physician...
- Perspective How to Think About “Medicare for All J.A. Morone
Florent Nkouaga, How Did Medicare for All Influence Trump’s...
- Review Article Necrotizing Soft-Tissue Infections D.L. Stevens and A.E. Bryant
16 paź 2024 · Those who used levonorgestrel IUDs had a 40 percent higher chance of developing breast cancer. For women in their 30s in the United States, that would take the risk of breast cancer from about 1 ...
16 paź 2024 · While the risk of developing breast cancer was low overall, using a hormonal IUD was associated with an “excess risk” of 14 cases per 10,000 women, according to the study, published in the ...
This study found that the overall risk of breast cancer among hormonal contraceptive users is low. Because of the low baseline risks in the age groups using hormonal contraception (ie, premenopausal women), the risk difference between hormonal contraception users and nonusers is small.
23 wrz 2022 · Findings In this cohort study of 2900 premenopausal women with early breast cancer enrolled in the prospective Cancer Toxicity study, 54.2% of patients reported contraceptive use at the time of diagnosis, with most patients using hormonal methods. Contraceptive use significantly decreased after primary treatment and during follow-up, when most ...
5 dni temu · A new study has found a link between hormonal intrauterine devices (IUDs) and breast cancer. The research is important, but media reports of a large increase in risk may be causing...
8 mar 2022 · Levonorgestrel intrauterine sustained release system (LNG-IUS) is an intrauterine hormonal contraceptive device. Breast cancer (BC) was the most common type of cancer in women in the world in 2020. The relationship between LNG-IUS and BC is controversial.
